Last reviewed · How we verify
NCT07367646
Development of Multidimensional Screening Tool for WMSDs
trial testing Survey Administration in Work-Related Musculoskeletal Disorders in 250 participants. Not yet recruiting.
31 December 2026
Quick facts
| Lead sponsor | Sahmyook University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 250 |
| Start date | 20 January 2026 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Survey Administration
Conditions studied
- Work-Related Musculoskeletal Disorders — all drugs for Work-Related Musculoskeletal Disorders →
- Musculoskeletal Diseases — all drugs for Musculoskeletal Diseases →
- Occupational Diseases — all drugs for Occupational Diseases →
Sponsor
Sahmyook University
Who can join
Adults 19 to 65, any sex, with Work-Related Musculoskeletal Disorders or Musculoskeletal Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to develop a multidimensional screening tool for Work-Related Musculoskeletal Disorders (WMSDs) and to evaluate its psychometric properties. The study involves a cross-sectional survey of approximately 250 workers in the bio-pharmaceutical industry to assess the tool's structural validity, internal consistency, construct validity, and measurement invariance following COSMIN guidelines.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07367646
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Survey Administration
Trials testing the same drug.
- NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
- NCT07441681 — Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive · Phase 3 · not yet recruiting
- NCT07377006 — Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer · NA · not yet recruiting
- NCT07390968 — Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Pati · Phase 2 · not yet recruiting
- NCT07493252 — A Behavioral Application for Improving Smoking Cessation Among Smokers · NA · not yet recruiting
Other Sahmyook University trials
Trials by the same sponsor.
- NCT07327541 — Cognitive, Physical, and Pain-Related Correlates in Community-Dwelling Older Adults · completed
- NCT07278791 — Survey-Based Study on Recovery Period Differences in Upper Extremity Injuries Among Indoor Climbers by Treatment Method · not yet recruiting
- NCT07138118 — Study of Blood Flow Restriction and Cognitive-Motor Dual Task Training to Improve Strength, Gait, and Balance in People · NA · completed
- NCT07134829 — The Effects of Stroboscopic Visual Conditions on Gait and Lower Limb Muscle Activity in Individuals With Chronic Ankle I · NA · not yet recruiting
- NCT06910254 — Effects of Overground Robot-Assisted Gait Training on Stroke-Related Sarcopenia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07367646 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sahmyook University
- Last refreshed: 26 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07367646.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing